MONICA WOOLDRIDGE: Open Payments
NPI 1578898383 · BRENTWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 16 payments from 6 companies in 2025. Trend: 2023 $45 · 2024 $348 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $245 |
| Janssen Pharmaceuticals, Inc | 5 | $211 |
| Teva Pharmaceuticals USA, Inc. | 3 | $184 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Alkermes, Inc. | 2 | $35 |
Products named: COBENFY, INVEGA SUSTENNA, UZEDY, AUSTEDO XR, INGREZZA, ARISTADA, ABILIFY MAINTENA, REXULTI.
Industry payments across CA — which companies pay providers there.
